Clinical Trial: The Effect of Dihydroartemisinin in PCOS
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Polycystic Ovary Syndrome
Study Type: Interventional
Official Title: The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome
Brief Summary:
Artemisinin has been widely used as a first-line antimalarial drug in routine clinical practice. In recent years, it has been reported that Artemisinin also has some significant anti-inflammatory, anti-tumor and immune-modulating effects. The investigators' previous studies discovered that Artemisinin dramatically reduced serum androgen levels and improved poly-cystic ovary syndrome(PCOS) in animals. Preliminary study by the investigators found that artemisinin derivatives are capable of reducing both androgen…
Read more